CA1247624A - Carbostyril derivatives - Google Patents

Carbostyril derivatives

Info

Publication number
CA1247624A
CA1247624A CA000431763A CA431763A CA1247624A CA 1247624 A CA1247624 A CA 1247624A CA 000431763 A CA000431763 A CA 000431763A CA 431763 A CA431763 A CA 431763A CA 1247624 A CA1247624 A CA 1247624A
Authority
CA
Canada
Prior art keywords
group
formula
lower alkyl
carbon
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000431763A
Other languages
English (en)
French (fr)
Inventor
Minoru Uchida
Kazuyuki Nakagawa
Makoto Komastu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP57117312A external-priority patent/JPS597169A/ja
Priority claimed from JP57117311A external-priority patent/JPS597168A/ja
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Application granted granted Critical
Publication of CA1247624A publication Critical patent/CA1247624A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
CA000431763A 1982-07-05 1983-07-04 Carbostyril derivatives Expired CA1247624A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP57117312A JPS597169A (ja) 1982-07-05 1982-07-05 カルボスチリル誘導体
JP117312/82 1982-07-05
JP57117311A JPS597168A (ja) 1982-07-05 1982-07-05 カルボスチリル誘導体
JP117311/82 1982-07-05

Publications (1)

Publication Number Publication Date
CA1247624A true CA1247624A (en) 1988-12-28

Family

ID=26455454

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000431763A Expired CA1247624A (en) 1982-07-05 1983-07-04 Carbostyril derivatives

Country Status (17)

Country Link
US (2) US4578381A (en, 2012)
AT (1) AT385506B (en, 2012)
AU (1) AU552717B2 (en, 2012)
CA (1) CA1247624A (en, 2012)
CH (1) CH654578A5 (en, 2012)
DE (1) DE3324034A1 (en, 2012)
DK (1) DK168288B1 (en, 2012)
ES (4) ES8500906A1 (en, 2012)
FI (1) FI80022C (en, 2012)
FR (1) FR2530626B1 (en, 2012)
GB (1) GB2123825B (en, 2012)
IT (1) IT1203676B (en, 2012)
NL (1) NL194165C (en, 2012)
NO (1) NO164835C (en, 2012)
PH (1) PH21650A (en, 2012)
PT (1) PT76980B (en, 2012)
SE (1) SE462848B (en, 2012)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582909A (en) * 1984-02-02 1986-04-15 Warner-Lambert Company Benzobicyclic lactam acids and derivatives as cognition activators
US4677112A (en) * 1984-02-02 1987-06-30 Warner-Lambert Company 1,2,3,4-tetrahydro-2-oxo-8-quinolineacetic and -propanoic acids and derivatives as cognition activators
US5215999A (en) * 1990-03-28 1993-06-01 Otsuka Pharmaceutical Co., Ltd. Quinoline derivative and antiulcer agent containing said quinoline derivative
US5258516A (en) * 1990-12-20 1993-11-02 Nc State University Optically pure D,E ring intermediates useful for the synthesis of camptothecin and camptothecin analogs
US5162532A (en) * 1990-12-20 1992-11-10 North Carolina State University Intermediates and method of making camptothecin and camptothecin analogs
US5264579A (en) * 1990-12-20 1993-11-23 North Carolina State University D ring intermediates for the synthesis of camptothecin and camptothecin analogs
US5254690A (en) * 1990-12-20 1993-10-19 North Carolina State University Alkoxymethylpyridine d-ring intermediates useful for the synthesis of camptpthecin and camptothecin analogs
US5315007A (en) * 1990-12-20 1994-05-24 North Carolina State University Process for making DE ring intermediates for the synthesis of camptothecin and camptothecin analogs
US5212317A (en) * 1990-12-20 1993-05-18 North Carolina State University Methods and intermediates for the assymmetric synthesis of camptothecin and camptothecin analogs
US5200524A (en) * 1990-12-20 1993-04-06 North Carolina State University Camptothecin intermediates and method of making same
CA2088582A1 (en) * 1991-06-07 1992-12-08 Katsuya Yamasaki Anti-diabetes mellitus
TW227558B (en, 2012) * 1992-05-14 1994-08-01 Otsuka Pharma Co Ltd
US5428166A (en) * 1992-06-18 1995-06-27 North Carolina State University Method of making asymmetric de ring intermediates for the synthesis of camptothecin and camptothecin analogs
US5459269A (en) * 1992-06-18 1995-10-17 North Carolina State University 14-halo-camptothecins
JP2872546B2 (ja) * 1992-11-26 1999-03-17 大塚製薬株式会社 腸粘膜障害保護剤
IS4164A (is) * 1993-06-11 1994-12-12 Ab Astra Efnasambönd sem hindra flæði magasýru
US5556863A (en) * 1993-06-11 1996-09-17 Astra Aktiebolag Compound for gastric acid secretion inhibition
AU683697B2 (en) * 1993-10-21 1997-11-20 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivative for inhibiting production of interleukin-8
WO1995012579A1 (en) * 1993-11-05 1995-05-11 Otsuka Pharmaceutical Company, Limited Bismuth salt of carbostyril derivatives for the treatment of peptic ulcers
US5496952A (en) * 1995-02-07 1996-03-05 North Carolina State University Method of making asymmetric DE ring intermediates for the synthesis of camptothecin and camptothecin analogs
AU6241796A (en) * 1995-06-27 1997-01-30 Takeda Chemical Industries Ltd. 4-acylamino(halogeno) alkyl-quinoline derivatives, their preparation and their use as melatonin agonists
AR004214A1 (es) * 1995-10-12 1998-11-04 Otsuka Pharma Co Ltd Una preparación de gotas oftálmicas para la cura de enfermedades oftálmicas
AU715764B2 (en) * 1996-01-23 2000-02-10 Shionogi & Co., Ltd. Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
CA2254974A1 (en) * 1996-05-20 1997-11-27 Mark Goulet Antagonists of gonadotropin releasing hormone
US6150522A (en) 1996-05-20 2000-11-21 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
KR100669823B1 (ko) 2001-02-20 2007-01-17 경동제약 주식회사 2-(4-클로로벤조일아미노)-3-[2(1ｈ)-퀴놀리논-4-일]프로피온산의 제조방법 및 그 중간체
ATE373502T1 (de) * 2003-07-30 2007-10-15 Otsuka Pharma Co Ltd Carbostyril-derivative zur beschleunigten speichelabsonderung
TWI340650B (en) * 2004-01-21 2011-04-21 Otsuka Pharma Co Ltd Amine saly of carbostyril derivative
JP3911008B2 (ja) * 2004-12-01 2007-05-09 大塚製薬株式会社 レバミピドの改良製造法
JP3892894B2 (ja) * 2005-04-28 2007-03-14 大塚製薬株式会社 カルボスチリル化合物の製造法
CN101870674B (zh) * 2009-04-21 2012-04-18 陕西大生化学科技有限公司 改进的瑞巴派特中间体的制备方法
US9248196B2 (en) * 2011-02-25 2016-02-02 Nuformix Limited Rebamipide complexes and cocrystals
CN102153512B (zh) * 2011-03-07 2013-03-27 江西同和药业有限责任公司 瑞巴派特中间体的制备方法
SA113340675B1 (ar) 2012-06-26 2015-08-16 استيش. كو.، ليمتد أدوية ريباميبايد تحضيرية جديدة، طريقة تحضيرها واستخدامها
CN108341775B (zh) * 2017-01-25 2021-03-16 重庆常捷医药有限公司 一种瑞巴派特中间体的合成方法
KR102190019B1 (ko) 2018-10-23 2020-12-15 삼진제약주식회사 쇼그렌 증후군 예방 또는 치료용 조성물
CN111057001A (zh) * 2019-12-23 2020-04-24 巨化集团公司制药厂 一种喹诺酮丙二酸酯化合物的制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3632628A (en) * 1968-04-15 1972-01-04 Colgate Palmolive Co Sulfonamidoalkyl amino acids
US4026897A (en) * 1974-01-31 1977-05-31 Otsuka Pharmaceutical Company 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-hydroxycarbostyril derivatives
US4313947A (en) * 1974-06-24 1982-02-02 Otsuka Pharmaceutical Co., Ltd. Platelet aggregation inhibiting 2-oxyindoles, their compositions and method of use
FI59246C (fi) * 1974-06-24 1981-07-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av benscykloamidderivat anvaendbara vid trombos- och emboliterapin
US4065572A (en) * 1976-02-13 1977-12-27 Merck & Co., Inc. Amino acids and esters thereof useful as antihypertensive agents
US4156734A (en) * 1976-02-13 1979-05-29 Merck & Co., Inc. Antihypertensive compositions containing an aryl-substituted alanine azo and an arylhydrazino-propionic acid
JPS5387368A (en) * 1977-01-12 1978-08-01 Otsuka Pharmaceut Co Ltd Carbostyril derivative
IE46852B1 (en) * 1977-06-10 1983-10-05 Otsuka Pharma Co Ltd Novel carbostyril derivatives
JPS5535018A (en) * 1978-09-01 1980-03-11 Otsuka Pharmaceut Co Ltd Alkaneamide derivative
JPS5583749A (en) * 1978-12-19 1980-06-24 Yoshitomi Pharmaceut Ind Ltd Quinolone derivative
JPS5585520A (en) * 1978-12-22 1980-06-27 Otsuka Pharmaceut Co Ltd Remedy for peptic ulcer
DE2927534A1 (de) * 1979-07-07 1981-01-08 Bayer Ag Optisch reine heterocyclische aminosaeuren, verfahren zu ihrer herstellung und ihre verwendung
JPS56122356A (en) * 1980-02-29 1981-09-25 Otsuka Pharmaceut Co Ltd Carbostyril derivative
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
JPS574974A (en) * 1980-06-11 1982-01-11 Otsuka Pharmaceut Co Ltd Carbostyril derivative
FI77852C (fi) * 1981-02-17 1989-05-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av nya, saosom hjaertmediciner anvaendbara substituerade amid- och (maettad heterocykel)karbonylkarbostyrilderivat.
US5225402A (en) * 1989-02-10 1993-07-06 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives

Also Published As

Publication number Publication date
ES523838A0 (es) 1984-11-01
IT8367731A0 (it) 1983-07-05
ES8504724A1 (es) 1985-05-01
DK307883A (da) 1984-01-06
PT76980B (en) 1986-01-09
ES530715A0 (es) 1985-05-16
NO164835B (no) 1990-08-13
GB8318174D0 (en) 1983-08-03
GB2123825A (en) 1984-02-08
SE8303813L (sv) 1984-01-06
DK168288B1 (da) 1994-03-07
NO832431L (no) 1984-01-06
ES8505347A1 (es) 1985-05-16
FR2530626B1 (fr) 1986-12-05
FI832425A0 (fi) 1983-07-01
GB2123825B (en) 1985-09-18
ES8500906A1 (es) 1984-11-01
AT385506B (de) 1988-04-11
DE3324034A1 (de) 1984-01-05
ES530716A0 (es) 1985-05-01
FI80022B (fi) 1989-12-29
SE462848B (sv) 1990-09-10
PT76980A (en) 1983-08-01
FR2530626A1 (fr) 1984-01-27
NL194165B (nl) 2001-04-02
ES530714A0 (es) 1985-05-16
DE3324034C2 (en, 2012) 1993-07-01
ATA245183A (de) 1987-09-15
IT1203676B (it) 1989-02-15
ES8505348A1 (es) 1985-05-16
DK307883D0 (da) 1983-07-04
NO164835C (no) 1990-11-21
PH21650A (en) 1988-01-13
US4578381A (en) 1986-03-25
FI80022C (fi) 1990-04-10
CH654578A5 (de) 1986-02-28
SE8303813D0 (sv) 1983-07-04
AU1653683A (en) 1984-01-12
USRE34722E (en) 1994-09-06
NL8302390A (nl) 1984-02-01
NL194165C (nl) 2001-08-03
AU552717B2 (en) 1986-06-19
FI832425L (fi) 1984-01-06

Similar Documents

Publication Publication Date Title
CA1247624A (en) Carbostyril derivatives
AU2002359376B2 (en) N, N'-substituted-1,3-diamino-2-hydroxypropane derivatives
DE69201748T2 (de) Pyrazinderivate.
JPH0610193B2 (ja) 新規１−置換オキシインド−ル−３−カルボキシアミド、その製法および抗炎症鎮痛組成物
KR880000434B1 (ko) 3-치환된 옥스인돌 화합물 및 그의 제조방법
MXPA02007461A (es) Deshidroaminoacidos.
US4224445A (en) Thienothiazine derivatives
KR19990063850A (ko) Nmda 길항제로서의 테트라히드로퀴놀린
IE41457B1 (en) Thienothiazine derivatives
PT86677B (pt) Processo para a preparacao de cinolina-carboxamidas e de composicoes farmaceuticas que as contem
DE69019920T2 (de) Benzocycloalkylaminopyridinamine und verwandte Verbindungen, Verfahren zu ihrer Herstellung, Zwischenverbindungen und ihre Verwendung als Arzneimittel.
US20060142385A1 (en) Inhibitors of matrix metalloproteinase
CH635092A5 (de) Verfahren zur herstellung neuer benzopyranderivate.
KR900006401B1 (ko) 카르보스티릴 유도체의 제조방법
US4737501A (en) Substituted piperazinyl oxindol compounds and cardiotonic compositions containing the same
JPS6254308B2 (en, 2012)
US3979397A (en) Pharmaceutically effective novel 3,4-dihydro-1,2- and 1,3-thiozolo [4,3a] is
DE69222818T2 (de) Kondensierte Naphthyridinderivate
JP2566843B2 (ja) ベンゾチアジン誘導体、その製法、及び医薬品として又は医薬品の合成中間体としてのその適用
US4213980A (en) Azathianaphthalenes
JPH0565273A (ja) カルボスチリル誘導体
WO1989000571A2 (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
US4526891A (en) Substituted alkyl amine derivatives of 6,11-dihydro-11-oxodibenz[b,e]oxepins
US3433802A (en) 3-(n-lower-alkylanilino)pyrrolidines
JP3725188B2 (ja) シクロヘキサン誘導体

Legal Events

Date Code Title Description
MKEX Expiry